| Literature DB >> 32407688 |
Yang Wu1, Dino J Ravnic2, Ibrahim T Ozbolat3.
Abstract
3D bioprinting directly into injured sites in a surgical setting, intraoperative bioprinting (IOB), is an effective process, in which the defect information can be rapidly acquired and then repaired via bioprinting on a live subject. In patients needing tissue resection, debridement, traumatic reconstruction, or fracture repair, the ability to scan and bioprint immediately following surgical preparation of the defect site has great potential to improve the precision and efficiency of these procedures. In this opinion article, we provide the reader with current major limitations of IOB from engineering and clinical points of view, as well as possibilities of future translation of bioprinting technologies from bench to bedside, and expound our perspectives in the context of IOB of composite and vascularized tissues.Entities:
Keywords: bioprinting technologies; clinical translation; intraoperative bioprinting; surgery
Year: 2020 PMID: 32407688 PMCID: PMC7666846 DOI: 10.1016/j.tibtech.2020.01.004
Source DB: PubMed Journal: Trends Biotechnol ISSN: 0167-7799 Impact factor: 19.536